Headline Details

U.S. FDA approves Pfizer's high profile breast cancer drug

Published on: Tue, 03 Feb 2015 21:09:27 UTC
News Agency: Reuters
Feb 3 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it had approved Pfizer Inc's experimental breast cancer drug Ibrance, a regulatory decision that came more than two months earlier than expected.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
3 more hostages released in Haiti, aid group says CNN
Far-right target critics with Twitter's new media policy BBC
Covid: UK red list criticised as 'travel apartheid' by Nigeria BBC
Joni Mitchell and Bette Midler pick up Kennedy Center Honors BBC
US reluctance to lift sanctions main hurdle to reviving 2015 pact, Iran official says CNN